Purchase Order 75N92B19P00053

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $20,680.00 on September 4, 2019, with completion by September 11, 2019. No set-aside applied. Place of performance is Bethesda, Maryland. The order procures genomic analysis instruments, consumables, or bioinformatics software from 10X Genomics' Chromium and Xenium platforms for single-cell and spatial transcriptomics research applications.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 20, 2019, with completion on September 27, 2019. The order is a firm fixed price, commercial item acquisition with no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures genomic analysis instruments, consumables, or related bioinformatics products from 10X Genomics' single-cell and spatial transcriptomics...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $185,142 on September 28, 2020 for reagents compatible with the Chromium Controller single cell platform.</p> <p>Work is performed at Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of October 30, 2020. No set-aside was used.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,285.50 on September 10, 2019, with completion by September 9, 2020. No set-aside applied. Work is performed at Bethesda, Maryland. The order is priced on a firm fixed price basis for genomic analysis instruments, consumables, or reagents consistent with the vendor's product portfolio of single-cell and spatial transcriptomics platforms and associated kits.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $19,100.00 on August 23, 2018. No set-aside was applied. Place of performance is Bethesda, Maryland. The order was completed by August 22, 2019. Pricing was firm fixed price for commercial genomic analysis instruments, consumables, or reagents—10X Genomics' core product portfolio in single-cell and spatial transcriptomics platforms supplied to federal research agencies.

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $19,100 on September 5, 2018. The order covers custom Chromium single cell 3 library and gel bead kits, with delivery expected by September 28, 2018. Work is performed at the vendor's Pleasanton, California facility. The procurement used firm fixed price, commercial-item pricing with no small business set-aside.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a purchase order to 10X Genomics, Inc. valued at $21,581 with an award date of December 12, 2017. Work is performed in Bethesda, Maryland. The order covers genomic analysis instruments and consumables under a firm fixed price arrangement with a period of performance from December 12, 2017 through December 11, 2018.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $24,084.00 on January 19, 2018. The order procures custom chromium single cell analysis reagents and consumables (3'/5' - 10X Genomics configuration). Performance occurs at 10X Genomics' facility in Pleasanton, California. The period of performance runs from January 19, 2018 through January 18, 2019, with ultimate completion targeted for February 28, 2018. The...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $24,896.00 on May 7, 2019, with an ultimate completion date of May 31, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis. Specific requirements are not detailed in the source.</p>

The National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $95,312 firm fixed price purchase order contract to 10X Genomics, Inc. for the purchase of a 10X Genomics Chromium X instrument. The contract is in response to a brand name or equal solicitation seeking a 10X Genomics Chromium X for use at NIAMS. 10X Genomics will deliver one Chromium X system to the agency's location in Pleasanton, California by September 24, 2022 to support...